Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS. (2025). Mediterranean Journal of Hematology and Infectious Diseases, 17(1), e2025026. https://doi.org/10.4084/MJHID.2025.026